back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2024-11-08 12:48 Tx date 2024-11-07 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
2,150,000 | |
| Older filings | ||||||
| Filed 2024-10-14 12:30 Tx date 2024-10-09 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,500
+250,000 vol $0.05 each |
2,400,000 | |
| Filed 2023-07-24 17:32 Tx date 2023-07-24 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
2,150,000 | |
| Filed 2023-07-17 15:06 Tx date 2023-07-13 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+300,000 vol $0.08 each |
2,400,000 | |
| Filed 2023-06-12 17:03 Tx date 2023-06-09 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+250,000 vol $0.10 each |
2,100,000 | |
| Filed 2022-07-25 14:59 Tx date 2022-07-21 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,000
+300,000 vol $0.09 each |
1,850,000 | |
| Filed 2022-04-14 11:12 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$4,500
+45,000 vol $0.10 each |
899,756 | |
| Filed 2022-04-14 10:59 Tx date 2022-04-12 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-4,500
-45,000 vol $0.10 each |
1,550,000 | |
| Filed 2021-06-02 13:22 Tx date 2021-06-02 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-15,000
-150,000 vol $0.10 each |
1,595,000 | |
| Filed 2021-05-28 15:38 Tx date 2021-05-26 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,250
+150,000 vol $0.115 each |
1,745,000 | |
| Filed 2021-01-06 12:01 Tx date 2021-01-05 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,000
+500,000 vol $0.23 each |
1,595,000 | |
| Filed 2021-01-04 15:43 Tx date 2021-01-03 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-25,000
-250,000 vol $0.10 each |
1,095,000 | |
| Filed 2020-01-16 19:02 Tx date 2020-01-15 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$15,000
+150,000 vol $0.10 each |
854,756 | |
| Filed 2020-01-16 18:48 Tx date 2020-01-15 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-15,000
-150,000 vol $0.10 each |
1,345,000 | |
| Filed 2019-01-31 Tx date 2019-01-29 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
1,495,000 | |
| Filed 2018-01-04 Tx date 2018-01-02 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
1,395,000 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
54 - Exercise of warrants
|
-150,000 vol |
1,245,000 | |
| Filed 2017-08-04 Tx date 2017-08-04 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$15,000
+150,000 vol $0.10 each |
704,756 | |
| Filed 2017-07-05 Tx date 2017-06-30 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,625
+112,500 vol $0.13 each |
861,762 | |
| Filed 2017-02-22 Tx date 2017-02-17 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
1,395,000 | |
| Filed 2015-08-12 Tx date 2015-08-10 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
53 - Grant of warrants
|
+150,000 vol |
1,245,000 | |
| Filed 2015-08-12 Tx date 2015-08-10 |
$QPT
Quest PharmaTech Inc. |
Vermette, Pierre Ralph
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$9,000
+150,000 vol $0.06 each |
749,262 | |